Skip to main content

FDA Approvals

FDA Approvals
Onivyde (Irinotecan Liposome Injection) a New Treatment Option for Patients with Metastatic Pancreatic Cancer
Read More
FDA Approvals, In the News
FDA Approves First Seasonal Influenza Vaccine Containing an Adjuvant
Read More
FDA Approvals, In the News
FDA Approves Bridion to Reverse Effects of Neuromuscular Blocking Drugs Used During Surgery
Read More
FDA Approvals, In the News
FDA Approves First Emergency Treatment for Overdose of Certain Types of Chemotherapy
Read More
FDA Approvals, In the News
FDA Approves New Oral Therapy to Treat ALK-Positive Lung Cancer
Read More
FDA Approvals, In the News
FDA Approves Empliciti, a New Immune-Stimulating Therapy to Treat Multiple Myeloma
Read More
FDA Approvals, In the News
FDA Approves Ninlaro, New Oral Medication to Treat Multiple Myeloma
Read More
FDA Approvals, In the News
FDA Approves Darzalex for Patients with Previously Treated Multiple Myeloma
Read More
FDA Approvals, In the News
FDA Approves Praxbind, the First Reversal Agent for the Anticoagulant Pradaxa
Read More
FDA Approvals
Vyvanse (Lisdexamfetamine Dimesylate): First FDA-Approved Drug for the Treatment of Adults with Binge-Eating Disorder
Read More
Page 18 of 20
Results 171 - 180 of 200